litlas
Log inCreate account

Thomas R. Fleming

Active 1978–2024

Also published as
Thomas R Fleming
101
Papers
43,572
Citations
79
h-index
98
i10-index

Citations

Citations per year for Thomas R. Fleming1966: 1 citations1979: 1 citations1981: 7 citations1982: 10 citations1983: 9 citations1984: 27 citations1985: 13 citations1986: 22 citations1987: 25 citations1988: 30 citations1989: 40 citations1990: 52 citations1991: 64 citations1992: 68 citations1993: 67 citations1994: 109 citations1995: 84 citations1996: 81 citations1997: 114 citations1998: 148 citations1999: 161 citations2000: 182 citations2001: 204 citations2002: 202 citations2003: 191 citations2004: 215 citations2005: 270 citations2006: 239 citations2007: 278 citations2008: 307 citations2009: 267 citations2010: 282 citations2011: 262 citations2012: 332 citations2013: 336 citations2014: 340 citations2015: 274 citations2016: 251 citations2017: 225 citations2018: 247 citations2019: 811 citations2020: 704 citations2021: 681 citations2022: 600 citations2023: 370 citations2024: 491 citations2025: 222 citations2026: 19 citations1967–1978: no citations, so these years are not shown1980: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,894 citing papers, 30.3% of this breakdownUnited Kingdom: 1,352 citing papers, 8.4% of this breakdownCanada: 769 citing papers, 4.8% of this breakdownGermany: 718 citing papers, 4.4% of this breakdownFrance: 648 citing papers, 4% of this breakdownItaly: 606 citing papers, 3.8% of this breakdownChina: 527 citing papers, 3.3% of this breakdownNetherlands: 492 citing papers, 3% of this breakdownAustralia: 463 citing papers, 2.9% of this breakdownSwitzerland: 398 citing papers, 2.5% of this breakdownSouth Africa: 379 citing papers, 2.3% of this breakdownSpain: 297 citing papers, 1.8% of this breakdown
0%30.3%Other 28.5%

Institutions

Fields

  • Medicine72.4%
  • Mathematics7.2%
  • Biochemistry, Genetics and Molecular Biology5.3%
  • Immunology and Microbiology3.7%
  • Nursing2.1%
  • Computer Science1.5%
  • Other7.8%

Topics

  • HIV/AIDS Research and Interventions6.4%
  • HIV Research and Treatment3.1%
  • HIV, Drug Use, Sexual Risk2.3%
  • HIV/AIDS drug development and treatment2.3%
  • Pulmonary Hypertension Research and Treatments2.3%
  • Adolescent Sexual and Reproductive Health1.8%
  • Other81.8%

Coauthors

All papers

Open in search
  1. Targeted Anticytokine Therapy in Patients With Chronic Heart Failure

    Authors: Douglas L. Mann, John J.V. McMurray, Milton Packer, Karl Swedberg, Jeffrey Borer, Wilson S. Colucci, Jacques Djian, Helmut Drexler, Arthur M. Feldman, Lars Køber, Henry Krum, Peter Liu, Markku S. Nieminen, Luigi Tavazzi, Dirk Jan van Veldhuisen, Anders Waldenström, Marshelle Warren, Arne Westheim, Faı̈ez Zannad, Thomas R. Fleming - Circulation 2004 cited by 1,230

  2. Prevention of HIV-1 Infection with Early Antiretroviral Therapy

    Authors: Myron S. Cohen, Ying Qing Chen, Marybeth McCauley, Theresa Gamble, Mina C. Hosseinipour, Nagalingeswaran Kumarasamy, James Hakim, Johnstone Kumwenda, Beatriz Grinsztejn, José Henrique Pilotto, Sheela Godbole, Sanjay Mehendale, Suwat Chariyalertsak, Breno Santos, Kenneth H. Mayer, Irving Hoffman, Susan H. Eshleman, Estelle Piwowar‐Manning, Lei Wang, Joseph Makhema, Lisa Mills, Guy de Bruyn, Ian Sanne, Joseph J. Eron, Joel E. Gallant, Diane V. Havlir, Susan Swindells, Heather J. Ribaudo, Vanessa Elharrar, David Burns, Taha E. Taha, Karin Nielsen‐Saines, David D. Celentano, Max Essex, Thomas R. Fleming - New England Journal of Medicine 2011 cited by 6,962

  3. Antiretroviral Therapy for the Prevention of HIV-1 Transmission

    Authors: Myron S. Cohen, Ying Qing Chen, Marybeth McCauley, Theresa Gamble, Mina C. Hosseinipour, Nagalingeswaran Kumarasamy, James Hakim, Johnstone Kumwenda, Beatriz Grinsztejn, José Henrique Pilotto, Sheela Godbole, Suwat Chariyalertsak, Breno Santos, Kenneth H. Mayer, Irving Hoffman, Susan H. Eshleman, Estelle Piwowar‐Manning, Leslie Cottle, Xinyi C. Zhang, Joseph Makhema, Lisa Mills, Ravindre Panchia, Sharlaa Faesen, Joseph J. Eron, Joel E. Gallant, Diane V. Havlir, Susan Swindells, Vanessa Elharrar, David Burns, Taha E. Taha, Karin Nielsen‐Saines, David D. Celentano, Max Essex, Sarah E. Hudelson, Andrew D. Redd, Thomas R. Fleming - New England Journal of Medicine 2016 cited by 1,726

  4. A Multiple Testing Procedure for Clinical Trials

    Authors: Peter C. O’Brien, Thomas R. Fleming - Biometrics 1979 cited by 3,349

  5. Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension

    Authors: Nazzareno Galiè, Hossein Ardeschir Ghofrani, Adam Torbicki, Robyn J. Barst, Lewis J. Rubin, David B. Badesch, Thomas R. Fleming, Tamiza Parpia, Gary Burgess, Angelo Branzi, Friedrich Grimminger, Marcin Kurzyna, Gérald Simonneau - New England Journal of Medicine 2005 cited by 2,470

  6. Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial

    Authors: Jon T. Giles, Naveed Sattar, Sherine E. Gabriel, Paul M. Ridker, Steffen Gay, Charles Warne, David Musselman, Laura Brockwell, Emma Shittu, Micki Klearman, Thomas R. Fleming - Arthritis & Rheumatology 2019 cited by 233

  7. Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial

    Authors: Elia M Pestana Knight, Sam Amin, Nadia Bahi-Buisson, Tim A Benke, J Helen Cross, Scott T Demarest, Heather E Olson, Nicola Specchio, Thomas R Fleming, Alex A Aimetti, Maciej Gasior, Orrin Devinsky, Elena Belousova, Oleg Belyaev, Bruria Ben-Zeev, Andreas Brunklaus, Michael A. Ciliberto, Francesca Darra, Ronald Davis, Valentina De Giorgis, Olga Doronina, Michael Fahey, Renzo Guerrini, Peter Heydemann, Olga Khaletskaya, Pawel Lisewski, Eric D. Marsh, Ahsan N. Moosa, Scott Perry, Sunny Philip, Rajsekar R. Rajaraman, Ben Renfroe, Russell P. Saneto, Ingrid E. Scheffer, Yoshimi Sogawa, Bernhardt Suter, Matthew T. Sweney, Daniel Tarquinio, Pierangelo Veggiotti, Geoff Wallace, Judy Weisenberg, Angus Wilfong, Elaine C. Wirrell, Muhammad Zafar, Marta Zolnowska - The Lancet Neurology 2022 cited by 152

  8. Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial

    Authors: Elia Pestana‐Knight, Sam Amin, Nadia Bahi‐Buisson, Tim A. Benke, J. Helen Cross, Scott Demarest, Heather E. Olson, Nicola Specchio, Thomas R. Fleming, Alex A. Aimetti, Maciej Ga̧sior, Orrin Devinsky, Marigold Trial Group - 2022 cited by 130

  9. Biomarkers and surrogate endpoints in clinical trials

    Authors: Thomas R. Fleming, John H. Powers - Statistics in Medicine 2012 cited by 530

  10. Surrogate End Points in Clinical Trials: Are We Being Misled?

    Authors: Thomas R. Fleming, David L. DeMets - Annals of Internal Medicine 1996 cited by 1,633

  11. Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on ‘Feels, Functions, Survives’. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency

    Authors: Ganesh Raghu, Marya Ghazipura, Thomas R. Fleming, Kerri I. Aronson, Jürgen Behr, Kevin M. Brown, Kevin R. Flaherty, Ella A. Kazerooni, Toby M. Maher, Luca Richeldi, Joseph A. Lasky, Jeffrey J. Swigris, Robert Busch, Lili Garrard, Dong-Hyun Ahn, Ji Li, Khalid Puthawala, Gabriela Rodal, Sally Seymour, Nargues Weir, Sonye K. Danoff, Neil Ettinger, Jonathan Goldin, Marilyn K. Glassberg, Letícia Kawano-Dourado, Nasreen Khalil, Lisa Lancaster, David A. Lynch, Yolanda Mageto, Imre Noth, Jessica Shore, Marlies Wijsenbeek, Robert S. Brown, Daniel Grogan, Dorothy Ivey, Patrycja Golińska, Banu A. Karimi-Shah, Fernando J. Martínez - American Journal of Respiratory and Critical Care Medicine 2024 cited by 76

  12. Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

    Authors: Charles G. Moertel, Thomas R. Fleming, John S. Macdonald, Daniel G. Haller, John A. Laurie, Phyllis J. Goodman, James S. Ungerleider, William A. Emerson, Douglas C. Tormey, John H. Glick, Michael H. Veeder, James A. Mailliard - New England Journal of Medicine 1990 cited by 2,258

  13. An introduction to the Marburg virus vaccine consortium, MARVAC

    Authors: Robert W. Cross, Ira M. Longini, Stephan Becker, Karin Bok, David Boucher, Miles W. Carroll, Janet Dı́az, William E. Dowling, Ruxandra Draghia‐Akli, James T. Duworko, John M. Dye, Michael A. Egan, Patricia Fast, Amy Finan, Courtney L. Finch, Thomas R. Fleming, Joan Fusco, Thomas W. Geisbert, Anthony Griffiths, Stephan Günther, Lisa E. Hensley, Anna N. Honko, Ruth Hunegnaw, Jocelyn Jakubik, Julie E. Ledgerwood, Kerstin Lühn, Demetrius Matassov, Jeffrey Meshulam, Emily V. Nelson, Christopher L. Parks, Roxana Rustomjee, David Safronetz, Lauren M. Schwartz, Dean Smith, Paul Smock, Ydrissa Sow, Christina F. Spiropoulou, Nancy J. Sullivan, Kelly L. Warfield, Daniel Wolfe, Courtney Woolsey, Roland Zahn, Ana María Henao-Restrepo, César Muñoz‐Fontela, Andrea Marzi - PLoS Pathogens 2022 cited by 54

  14. When to update COVID-19 vaccine composition

    Authors: Rebecca Grant, Jilian A. Sacks, Priya Abraham, Supamit Chunsuttiwat, Cheryl Cohen, J. Peter Figueroa, Thomas R. Fleming, Paul V. A. Fine, David Goldblatt, Hideki Hasegawa, C. Raina MacIntrye, Ziad A. Memish, Elizabeth Miller, Sérgio de Andrade Nishioka, Amadou A. Sall, Samba O. Sow, Oyewale Tomori, Youchun Wang, Maria D. Van Kerkhove, Marie-Ange Wambo, Homa Attar Cohen, Samuel Mesfin, James R. Otieno, Lorenzo Subissi, Sylvie Briand, David E. Wentworth, Kanta Subbarao - Nature Medicine 2023 cited by 51

  15. Counting Processes and Survival Analysis.

    Authors: Dorota M. Dabrowska, Thomas R. Fleming, David P. Harrington - Journal of the American Statistical Association 1992 cited by 2,315

  16. High-Dose Vitamin C versus Placebo in the Treatment of Patients with Advanced Cancer Who Have Had No Prior Chemotherapy

    Authors: Charles G. Moertel, Thomas R. Fleming, Edward T. Creagan, Joseph Rubin, Michael J. O’Connell, Matthew M. Ames - New England Journal of Medicine 1985 cited by 627

  17. ESTIMATING THE PROPORTION OF TREATMENT EFFECT EXPLAINED BY A SURROGATE MARKER

    Authors: D. Y. Lin, Thomas R. Fleming, Victor De Gruttola - Statistics in Medicine 1997 cited by 511

  18. openalex_id:w3201408162

    Authors: Philip R. Krause, Thomas R. Fleming, Richard Peto, Ira M. Longini, J. Peter Figueroa, Jonathan A C Sterne, Alejandro Cravioto, Helen Rees, Julian P. T. Higgins, Isabelle Boutron, Hongchao Pan, Marion F. Gruber, Narendra K. Arora, Fatema Kazi, Rogerio Gaspar, Soumya Swaminathan, Michael J. Ryan, Ana‐Maria Henao‐Restrepo cited by 372

  19. The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough

    Authors: Surinder S. Birring, Thomas R. Fleming, Sérgio Matos, A A Raj, David H. Evans, Ian Pavord - European Respiratory Journal 2008 cited by 303

  20. SARS-CoV-2 Variants and Vaccines

    Authors: Philip R. Krause, Thomas R. Fleming, Ira M. Longini, Richard Peto, Sylvie Briand, David L. Heymann, Valerie Beral, Matthew D. Snape, Helen Rees, Alba-Maria Ropero, Ran D. Balicer, Jakob P. Cramer, César Muñoz‐Fontela, Marion F. Gruber, Rogerio Gaspar, Jerome Amir Singh, Kanta Subbarao, Maria D. Van Kerkhove, Soumya Swaminathan, Michael J. Ryan, Ana‐Maria Henao‐Restrepo - New England Journal of Medicine 2021 cited by 425

  21. FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit

    Authors: Jason S. Kim, Silvana Borges, Daniel J. Clauw, Philip G. Conaghan, David T. Felson, Thomas R. Fleming, R. Gläser, Elizabeth Hart, Marc C. Hochberg, Yura Kim, Virginia B. Kraus, Larissa Lapteva, Xiaojuan Li, Sharmila Majumdar, Timothy E. McAlindon, Ali Mobasheri, Tuhina Neogi, Frank W. Roemer, Rebecca Rothwell, Robert Shibuya, Jeffrey Siegel, Lee S. Simon, Kurt P. Spindler, Nikolay P. Nikolov - Seminars in Arthritis and Rheumatism 2022 cited by 29

  22. Prognosis in primary biliary cirrhosis: Model for decision making

    Authors: Rolland E. Dickson, Patricia M. Grambsch, Thomas R. Fleming, Lloyd D. Fisher, Alice Langworthy - Hepatology 1989 cited by 822

  23. A class of rank test procedures for censored survival data

    Authors: David P. Harrington, Thomas R. Fleming - Biometrika 1982 cited by 1,175

  24. Surrogate Endpoints And FDA’s Accelerated Approval Process

    Authors: Thomas R. Fleming - Health Affairs 2005 cited by 248